Key result
Genomic and transcriptomic studies have identified over 100 atrial fibrillation risk loci, suggesting that impaired responses to cell stress in genetically susceptible individuals predispose to AF.
Genomic and transcriptomic studies in atrial fibrillation have identified over 100 risk loci and suggest that impaired responses to cell stress predispose to AF, highlighting potential novel therapeutic targets.
Answers are grounded in this paper and cite their sources.
AF genetic risk assessment remains premature; extends loci discovery with a cell stress dual-risk hypothesis for targeted research.
From the bedside of patients contributing samples to large genome-wide association studies for atrial fibrillation (AF), over 100 AF risk loci have been identified. The top locus is near a gene implicated in pulmonary vein formation; the ostia of the pulmonary veins harbor initiating triggers of AF, and isolation of these areas is the cornerstone of ablation therapies for AF. Transcriptomic studies suggest that AF is associated with impaired or overwhelmed responses to cell stress. A dual risk model proposes that in genetically-susceptible individuals, inadequate transcriptional responses to stress predispose to AF in later life. Drugs targeting metabolic, oxidative, or protein handling stress may be novel upstream agents to bring back to the bedside for study in the prevention of AF.
No takes yet. Share an insight, caveat, or question.
Chung et al. (2019) conducted a review in Atrial Fibrillation. Genomic and transcriptomic studies have identified over 100 atrial fibrillation risk loci, suggesting that impaired responses to cell stress in genetically susceptible individuals predispose to AF.
Synapse has enriched 10 related papers. Consider them for comparative context: